Lundbeck
HLUN-B.CO
$4.73
Share price
0.00%
Change (1 day)
-9.73%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Lundbeck (HLUN-B.CO) - Total assets
Total assets on the balance sheet as of December 2023 : $5.54 B
According to Lundbeck 's latest financial reports the company's total assets are $5.54 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Lundbeck - Total assets on balance sheet (from 2009 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $5.54 B | 2.72% |
| 2022-12-31 | $5.39 B | 2.23% |
| 2021-12-31 | $5.27 B | -11.41% |
| 2020-12-31 | $5.95 B | 4.16% |
| 2019-12-31 | $5.71 B | 62.17% |
| 2018-12-31 | $3.52 B | 10.7% |
| 2017-12-31 | $3.18 B | 11.3% |
| 2016-12-31 | $2.86 B | -8.43% |
| 2015-12-31 | $3.12 B | -25.37% |
| 2014-12-31 | $4.18 B | -4.37% |
| 2013-12-31 | $4.37 B | 14.51% |
| 2012-12-31 | $3.82 B | 6.88% |
| 2011-12-31 | $3.57 B | 11.33% |
| 2010-12-31 | $3.21 B | -2.61% |
| 2009-12-31 | $3.29 B | 40.27% |
| 2008-12-31 | $2.35 B | -2.49% |
| 2007-12-31 | $2.41 B | 16.97% |
| 2006-12-31 | $2.06 B | 12.01% |
| 2005-12-31 | $1.84 B | -12.12% |
| 2004-12-31 | $2.09 B |